103 related articles for article (PubMed ID: 18496192)
1. Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene.
Gómez-Esteban JC; Lezcano E; Zarranz JJ; González C; Bilbao G; Lambarri I; Rodríguez O; Garibi J
Neurosurgery; 2008 Apr; 62(4):857-62; discussion 862-3. PubMed ID: 18496192
[TBL] [Abstract][Full Text] [Related]
2. Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers.
Sayad M; Zouambia M; Chaouch M; Ferrat F; Nebbal M; Bendini M; Lesage S; Brice A; Brahim Errahmani M; Asselah B
BMC Neurosci; 2016 Feb; 17():6. PubMed ID: 26831335
[TBL] [Abstract][Full Text] [Related]
3. Sustained response to deep brain stimulation in LRRK2 parkinsonism with the Y1699C mutation.
Perju-Dumbrava LD; McDonald M; Kneebone AC; Long R; Thyagarajan D
J Parkinsons Dis; 2012; 2(4):269-71. PubMed ID: 23938256
[TBL] [Abstract][Full Text] [Related]
4. Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
Schüpbach M; Lohmann E; Anheim M; Lesage S; Czernecki V; Yaici S; Worbe Y; Charles P; Welter ML; Pollak P; Dürr A; Agid Y; Brice A
Mov Disord; 2007 Jan; 22(1):119-22. PubMed ID: 17080443
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques.
Simón-Sánchez J; Martí-Massó JF; Sánchez-Mut JV; Paisán-Ruiz C; Martínez-Gil A; Ruiz-Martínez J; Sáenz A; Singleton AB; López de Munain A; Pérez-Tur J
Mov Disord; 2006 Nov; 21(11):1954-9. PubMed ID: 16991141
[TBL] [Abstract][Full Text] [Related]
6. Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2.
Martí-Massó JF; Ruiz-Martínez J; Bolaño MJ; Ruiz I; Gorostidi A; Moreno F; Ferrer I; López de Munain A
Mov Disord; 2009 Oct; 24(13):1998-2001. PubMed ID: 19735093
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
8. Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.
Estanga A; Rodriguez-Oroz MC; Ruiz-Martinez J; Barandiaran M; Gorostidi A; Bergareche A; Mondragon E; Lopez de Munain A; Marti-Masso JF
Parkinsonism Relat Disord; 2014 Oct; 20(10):1097-100. PubMed ID: 25127457
[TBL] [Abstract][Full Text] [Related]
9. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 R1441G in Spanish patients with Parkinson's disease.
Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic nucleus deep brain stimulation for Parkinson's disease: evidence for effectiveness and limitations from 12 years' experience.
; Chan AY; Yeung JH; Mok VC; Ip VH; Wong A; Kuo SH; Chan DT; Zhu XL; Wong E; Lau CK; Wong RK; Tang V; Lau C; Poon WS
Hong Kong Med J; 2014 Dec; 20(6):474-80. PubMed ID: 25345997
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.
Gillardon F; Schmid R; Draheim H
Neuroscience; 2012 Apr; 208():41-8. PubMed ID: 22342962
[TBL] [Abstract][Full Text] [Related]
13. Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease.
Funalot B; Nichols WC; Pérez-Tur J; Mercier G; Lucotte G
Genet Test; 2006; 10(4):290-3. PubMed ID: 17253937
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
16. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.
Zibetti M; Merola A; Rizzi L; Ricchi V; Angrisano S; Azzaro C; Artusi CA; Arduino N; Marchisio A; Lanotte M; Rizzone M; Lopiano L
Mov Disord; 2011 Nov; 26(13):2327-34. PubMed ID: 22012750
[TBL] [Abstract][Full Text] [Related]
17. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort.
Bras JM; Guerreiro RJ; Ribeiro MH; Januario C; Morgadinho A; Oliveira CR; Cunha L; Hardy J; Singleton A
Mov Disord; 2005 Dec; 20(12):1653-5. PubMed ID: 16149095
[TBL] [Abstract][Full Text] [Related]
18. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
[TBL] [Abstract][Full Text] [Related]
19. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism.
Moro E; Volkmann J; König IR; Winkler S; Hiller A; Hassin-Baer S; Herzog J; Schnitzler A; Lohmann K; Pinsker MO; Voges J; Djarmatic A; Seibler P; Lozano AM; Rogaeva E; Lang AE; Deuschl G; Klein C
Neurology; 2008 Apr; 70(14):1186-91. PubMed ID: 18378882
[TBL] [Abstract][Full Text] [Related]
20. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
